CSN Login
Members Online: 3

You are here

PX-866 with Cetuximab (Erbitux) going into Phase Two

Posts: 1956
Joined: Oct 2009

"PX-866 is a pan inhibitor of the PI-3K/PTEN/AKT pathway, a critical cell signalling that is activated in many types of cancer"-(CRC being one of them)
Its made by Oncothyreon Inc and I read about it at prenewswire.com

with an upcoming meeting of ASCO expect more in the news as drug manufacturers generally present their latest stuff at such conventions

Subscribe to Comments for "PX-866 with Cetuximab (Erbitux) going into Phase Two"